AndrewLowyMD
General Surgery • La Jolla, CASurgical Oncology (Other than Breast)
Professor of Surgery, UCSD
Dr. Lowy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3855 Health Sciences Drive
Moores Cancer Center
La Jolla, CA 92093Phone+1 858-822-2124Fax+1 858-228-0987
Summary
- I am a surgical oncologist with a primary interest in cancers of the pancreas, and GI tract. My expertise is in pancreatic cancer surgery and in the management of complex gastrointestinal cancers , including heated intraperitoneal chemotherapy (HIPEC), to treat advanced abdominal cancers.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 1988 - 1993
Weill Cornell MedicineClass of 1988
Certifications & Licensure
CA State Medical License 2007 - 2026
OH State Medical License 1996 - 2008
TX State Medical License 1993 - 1997
NY State Medical License 1989 - 1994- American Board of Surgery Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2020
- Top Doctors:San Diego Area Castle Connolly, 2013-2020
- America's Top Doctors for Cancer Castle Connolly, 2010-2020
- Join now to see all
Clinical Trials
- Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy Start of enrollment: 2011 Jul 01
- Adjuvant Aflibercept for Metastatic Colorectal Cancer Start of enrollment: 2012 Dec 01
Publications & Presentations
PubMed
- Inhibition of SUMOylation Induces Adaptive Antitumor Immunity against Pancreatic Cancer through Multiple Effects on the Tumor Microenvironment.Suna Erdem, Hyojae James Lee, Jayanth Surya Narayanan Shankara Narayanan, Mohottige Don Neranjan Tharuka, Jorge De la Torre
Molecular Cancer Therapeutics. 2024-11-04 - Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations.Jonathan Weitz, Daisuke Nishizaki, Joy Liau, Jay Patel, Isabella Ng
Journal of Clinical Oncology. 2024-10-16 - 2 citationsIntratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma.Max M Wattenberg, Sarah Colby, Ignacio Garrido-Laguna, Yuqing Xue, Renee Chang
Gastroenterology. 2024-06-01
Journal Articles
- Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis Is an Independent Predictor of Progression-Free SurvivalAndrew M Lowy, Kaitlyn J Kelly, Joel M Baumgartner, Lisa Tran, Razelle Kurzrock, Annals of Surgical Oncology
Press Mentions
Breast Cancer Drug Offers New Hope for Treating Rare Appendix CancerOctober 18th, 2024- Study: Breast Cancer Drug Shows Potential for Rare Appendix CancerOctober 16th, 2024
- Appendiceal Cancer Gets Its Own Preclinical ModelNovember 28th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
